We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+16.03%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$3.11B
AUM Growth
+$364M
Cap. Flow
+$33.6M
Cap. Flow %
1.08%
Top 10 Hldgs %
20.36%
Holding
317
New
24
Increased
113
Reduced
139
Closed
27

Sector Composition

Rank Sector Weight
1 Healthcare 22.48%
2 Industrials 19.28%
3 Technology 19.21%
4 Communication Services 10.31%
5 Consumer Discretionary 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
251
ExxonMobil
XOM
$634B
$935K 0.03%
11,571
-400
-3% -$30.5K
LHX icon
252
L3Harris
LHX
$53.4B
$895K 0.03%
5,606
-450
-7% -$69.3K
CVX icon
253
Chevron
CVX
$366B
$797K 0.03%
6,467
DIS icon
254
Walt Disney
DIS
$181B
$772K 0.02%
6,950
ABT icon
255
Abbott
ABT
$187B
$761K 0.02%
9,524
-400
-4% -$29.8K
TACO
256
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
$750K 0.02%
74,524
-84,004
-53% -$874K
ABBV icon
257
AbbVie
ABBV
$435B
$748K 0.02%
9,282
IWM icon
258
iShares Russell 2000 ETF
IWM
$81.9B
$743K 0.02%
4,855
-4,349
-47% -$654K
NVCR icon
259
NovoCure
NVCR
$1.91B
$733K 0.02%
15,215
+600
+4% +$28.9K
LDL
260
DELISTED
Lydall, Inc.
LDL
$689K 0.02%
+29,370
New +$743K
MRK icon
261
Merck
MRK
$318B
$671K 0.02%
8,456
RYTM icon
262
Rhythm Pharmaceuticals
RYTM
$7.96B
$636K 0.02%
+23,202
New +$667K
HURN icon
263
Huron Consulting
HURN
$2.42B
$631K 0.02%
13,359
+9,018
+208% +$445K
J icon
264
Jacobs Solutions
J
$17B
$627K 0.02%
10,083
+121
+1% +$6.82K
MCO icon
265
Moody's
MCO
$82.7B
$600K 0.02%
3,311
-25
-0.7% -$4.11K
ADMS
266
DELISTED
Adamas Pharmaceuticals
ADMS
$586K 0.02%
82,413
+59,485
+259% +$535K
PEP icon
267
PepsiCo
PEP
$190B
$584K 0.02%
4,765
COHR icon
268
Coherent
COHR
$74.2B
$551K 0.02%
14,784
-284
-2% -$10.5K
MEET
269
DELISTED
The Meet Group, Inc. Common Stock
MEET
$533K 0.02%
105,871
-63,768
-38% -$355K
WMT icon
270
Walmart Inc
WMT
$890B
$512K 0.02%
15,750
CAG icon
271
Conagra Brands
CAG
$7.23B
$418K 0.01%
15,060
-221
-1% -$5.07K
INTC icon
272
Intel
INTC
$513B
$381K 0.01%
7,100
AMRS
273
DELISTED
Amyris Inc.
AMRS
$373K 0.01%
178,670
+129,050
+260% +$509K
PG icon
274
Procter & Gamble
PG
$339B
$365K 0.01%
3,504
-340
-9% -$33.1K
IWO icon
275
iShares Russell 2000 Growth ETF
IWO
$15B
$352K 0.01%
1,788
-91,622
-98% -$17.4M

Similar funds

Rice Hall James & Associates's Q1 2019 Portfolio in Review

As of Q1 2019, Rice Hall James & Associates held 317 positions worth $3.11B, up 13% from $2.74B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Rice Hall James & Associates's Q1 2019 filing shows 24 new, 113 increased, 139 reduced and 27 closed positions. Its largest new stake was Vonage Holdings Corporation: 2,004,892 shares worth $20.1M. The largest sale was Integrated Device Technology I, an estimated $59.8M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Industrials and Technology.

  • Rice Hall James & Associates's largest Q1 2019 buy was Vonage Holdings Corporation: 2,004,892 shares worth $20.1M.
  • Rice Hall James & Associates added most to Euronet Worldwide in Q1 2019, an estimated $26M increase.
  • Rice Hall James & Associates's biggest Q1 2019 reduction was iShares Russell 2000 Growth ETF, cutting an estimated $17.4M.
  • Rice Hall James & Associates fully exited Integrated Device Technology I in Q1 2019, selling an estimated $59.8M.
  • Rice Hall James & Associates's ten largest holdings make up 20% of its $3.11B portfolio in Q1 2019.
  • Rice Hall James & Associates opened 24 new positions and closed 27 in Q1 2019.
  • Rice Hall James & Associates's portfolio value rose 13% quarter-over-quarter to $3.11B.

Based on Rice Hall James & Associates's 13F filing for Q1 2019, filed 1 May 2019.